-
4
-
-
0036186485
-
-
Yamamoto H., Eikyu T., Okuda S., Kawabata K., Takasugi H., Tanaka H., Matsumoto S., Matsumoto Y., Tawara S. Bioorg. Med. Chem. 10:2002;1535.
-
(2002)
Bioorg. Med. Chem.
, vol.10
, pp. 1535
-
-
Yamamoto, H.1
Eikyu, T.2
Okuda, S.3
Kawabata, K.4
Takasugi, H.5
Tanaka, H.6
Matsumoto, S.7
Matsumoto, Y.8
Tawara, S.9
-
8
-
-
0024952059
-
-
Cecchi L., Colotta V., Melani F., Palazzino G., Filacchioni G., Martini C., Giannaccini G., Lucacchini A. J. Pharm. Sci. 78:1989;437-442.
-
(1989)
J. Pharm. Sci.
, vol.78
, pp. 437-442
-
-
Cecchi, L.1
Colotta, V.2
Melani, F.3
Palazzino, G.4
Filacchioni, G.5
Martini, C.6
Giannaccini, G.7
Lucacchini, A.8
-
9
-
-
0037136019
-
-
Yuan J., Gulianello M., De Lombaert S., Brodbeck R., Kieltyka A., Hodgetts K.J. Bioorg. Med. Chem. Lett. 12:2002;2133-2136.
-
(2002)
Bioorg. Med. Chem. Lett.
, vol.12
, pp. 2133-2136
-
-
Yuan, J.1
Gulianello, M.2
De Lombaert, S.3
Brodbeck, R.4
Kieltyka, A.5
Hodgetts, K.J.6
-
12
-
-
0029846281
-
-
Pd/C
-
Pd/C Vincentini C.B., Guarneri M., Scatturin A., Giori P., Heilman W. Farmaco. 51:1996;609.
-
(1996)
Farmaco
, vol.51
, pp. 609
-
-
Vincentini, C.B.1
Guarneri, M.2
Scatturin, A.3
Giori, P.4
Heilman, W.5
-
13
-
-
0001954003
-
-
Vincentini C.B., Ferretti V., Veronese A.C., Guarneri M., Manfrini M., Giori P. Heterocycles. 41:1995;497.
-
(1995)
Heterocycles
, vol.41
, pp. 497
-
-
Vincentini, C.B.1
Ferretti, V.2
Veronese, A.C.3
Guarneri, M.4
Manfrini, M.5
Giori, P.6
-
14
-
-
0342573319
-
-
Vincentini C.B., Veronese A.C., Poli T., Guarneri M., Giori P. Heterocycles. 32:1991;727.
-
(1991)
Heterocycles
, vol.32
, pp. 727
-
-
Vincentini, C.B.1
Veronese, A.C.2
Poli, T.3
Guarneri, M.4
Giori, P.5
-
16
-
-
0033762894
-
-
Aiello E., Aiello S., Mingoia F., Bacchi A., Pelizzi G., Musiu C., Setzu M.G., Pani A., La Colla P., Marongiu M.E. Bioorg. Med. Chem. 8:2000;2719.
-
(2000)
Bioorg. Med. Chem.
, vol.8
, pp. 2719
-
-
Aiello, E.1
Aiello, S.2
Mingoia, F.3
Bacchi, A.4
Pelizzi, G.5
Musiu, C.6
Setzu, M.G.7
Pani, A.8
La Colla, P.9
Marongiu, M.E.10
-
21
-
-
0037413528
-
-
Evans G.B., Furneaux R.H., Gainsford G.J., Hanson J.C., Kicska G.A., Sauve A.A., Schramm V.L., Tyler P.C. J. Med. Chem. 46:2003;155.
-
(2003)
J. Med. Chem.
, vol.46
, pp. 155
-
-
Evans, G.B.1
Furneaux, R.H.2
Gainsford, G.J.3
Hanson, J.C.4
Kicska, G.A.5
Sauve, A.A.6
Schramm, V.L.7
Tyler, P.C.8
-
22
-
-
0026018962
-
-
A number of β-diketones are commercially available. Those diketones that were not commercially available were synthesized following the procedure of Popic et al.
-
A number of β-diketones are commercially available. Those diketones that were not commercially available were synthesized following the procedure of Popic et al. Popic V.V., Korneev S.M., Nikolaev V.A., Korobitsyna I.K. Synthesis. 1991;195-198.
-
(1991)
Synthesis
, pp. 195-198
-
-
Popic, V.V.1
Korneev, S.M.2
Nikolaev, V.A.3
Korobitsyna, I.K.4
-
25
-
-
1242290736
-
-
New Food Ind. 20:1978;20.
-
(1978)
New Food Ind.
, vol.20
, pp. 20
-
-
-
27
-
-
1242335624
-
-
Nitrosamines. 1988;117.
-
(1988)
Nitrosamines
, pp. 117
-
-
-
28
-
-
85030896167
-
-
note
-
There were numerous uncharacterized side products formed in the reaction. However, the overall yield of 50% was still an improvement over the two-step protocol for this compound (40%).
-
-
-
-
29
-
-
85030897274
-
-
note
-
The nitroso pyrazole compound was formed after 1 h (TLC and LCMS analysis).
-
-
-
-
30
-
-
85030890620
-
-
note
-
3O (187.20) MS (ESI) 188 (M+H).
-
-
-
|